---
title: "KLY SPORTS released its 2024 annual performance, with a net profit attributable to the parent company of 81.2251 million yuan, a decrease of 16.20%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236805807.md"
description: "KLY SPORTS released its 2024 annual report, with operating revenue of 687 million yuan, a year-on-year increase of 12.74%. The net profit attributable to shareholders was 81.2251 million yuan, a year-on-year decrease of 16.20%. The net profit after deducting non-recurring gains and losses was 81.2493 million yuan, a year-on-year increase of 20.77%. The basic earnings per share were 1.22 yuan, and it plans to distribute a cash dividend of 5 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-21T13:31:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236805807.md)
  - [en](https://longbridge.com/en/news/236805807.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236805807.md)
generator: "portal-rs"
---

# KLY SPORTS released its 2024 annual performance, with a net profit attributable to the parent company of 81.2251 million yuan, a decrease of 16.20%

According to the Zhitong Finance APP, KLY SPORTS (301287.SZ) released its 2024 annual report, showing an operating income of 687 million yuan, a year-on-year increase of 12.74%. The net profit attributable to shareholders of the listed company was 81.2251 million yuan, a year-on-year decrease of 16.20%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 81.2493 million yuan, a year-on-year increase of 20.77%. The basic earnings per share were 1.22 yuan. In addition, it plans to distribute a cash dividend of 5 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [301287.CN](https://longbridge.com/en/quote/301287.CN.md)

## Related News & Research

- [Pinnacle West Capital Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/296614145.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [TAESA energizes Garabi 2 converter, adding about R$ 24.2 million to Saíra annual revenue entitlement](https://longbridge.com/en/news/296538089.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)
- [Zephyr Introduces the Presrv™ Gourmet Clear Ice Machine](https://longbridge.com/en/news/296352842.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**